Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04610489 · ClinicalTrials.gov registry record · NA
Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)
A NA study, sponsored by Carilion Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT04610489 is a NA study that was terminated before completion, run by Carilion Clinic. The registered enrollment target is 117 participants.
The verdict
NCT04610489, a NA study, was terminated before completion, sponsored by Carilion Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
A comparison of a direct antigen test for SARS-CoV-2 obtained by mid-turbinate swab with the reference standard rt-PCR test obtained by nasopharyngeal swab in outpatients with symptoms compatible with COVID-19.
Interventions
- DIAGNOSTIC_TEST Quidel Sofia SARS Antigen FIA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2021-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04610489
The ClinicalTrials.gov registry entry for NCT04610489 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quidel Sofia SARS Antigen FIA is the first listed.
NCT04610489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04610489 about?
NCT04610489 is a clinical study titled "Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)". A comparison of a direct antigen test for SARS-CoV-2 obtained by mid-turbinate swab with the reference standard rt-PCR test obtained by nasopharyngeal swab in outpatients with symptoms compatible with COVID-19.
What is the current status of trial NCT04610489?
This trial is currently terminated. It is a NA study. The enrollment target is 117 participants. The study started on 2020-11-13. Estimated completion is 2021-03-10.
What interventions are being tested in trial NCT04610489?
The interventions under investigation include: Quidel Sofia SARS Antigen FIA (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04610489?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.